Advertisement

Topics

Cancer Research Ventures Company Profile

19:11 EDT 26th March 2019 | BioPortfolio

Cancer Research Ventures Ltd (CRV) and its forerunner Cancer Research Campaign Technology Limited (CRCT) have been providing technology transfer services to cancer researchers since 1987 with the aim of developing much needed new treatments from cancer research.

Location

6-10 Cambridge Terrace, Regents Park
London
NW1 4JL
United Kingdom

Contact

Phone: +44 (0) 207 224 1333
Fax: +44 (0) 207 291 3601
Email: info@cancerventures.co.uk


News Articles [3611 Associated News Articles listed on BioPortfolio]

Startup Future Family rakes in $10M to expand subscription fertility service

Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.

Reid Leonard : Merck Research Ventures Fund, providing power to the Licensing team

In this episode of PharmaTelevision News Review, Fintan Walton talks to Reid Leonard, Managing Director of Merck Research Ventures Fund

Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy

Dallas—Peloton Therapeutics, which is developing small molecule drugs to treat cancer, announced Wednesday that it has raised $150 million in a Series E funding round. The new financing was led ...

VelosBio closes $58mm Series A round

Oncology start-up VelosBio Inc. raised $58mm through its Series A round. Arix Bioscience and Sofinnova Ventures co-led and were joined by Pappas Ventures, Chiesi Ventures, and returning backers Takeda...

Neurotherapeutics discovery start-up System1 closes $25mm Series A round

System1 Biosciences Inc. (neurological and psychiatric disorder drug discovery using phenotypic screening) completed a $25mm Series A round co-led by CRV and Pfizer Ventures (both add board members). ...

Index Ventures, GSK and Johnson & Johnson launch exciting new Venture Fund

In this interview, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Francesco de Rubertis of Index Ventures, Paul Stoffels, Worldwide Chairman of Johnson & Johnson Pharmaceuticals ...

Series B round brings $12.6mm to Gauss Surgical

Gauss Surgical Inc. (markets the Triton system for real-time blood loss monitoring during surgery and childbirth) raised $12.6mm in its Series B round from Providence Ventures (lead), Jump Capital, Pr...

Top US institutions win global competition in cancer research

(Cancer Research UK) The US will lead three new global research projects, tackling some of the biggest challenges in cancer research, it was announced today by Cancer Research UK.

PubMed Articles [7507 Associated PubMed Articles listed on BioPortfolio]

Molecular Profiling of Pancreatic Cancer Patients-Response.

Promoting scientist-advocate collaborations in cancer research: why and how.

Advocates bring unique and important viewpoints to the cancer research process, ensuring that scientific and medical advances are patient-centered and relevant. In this article, we discuss the benefit...

Research progress on interleukin-6 in lung cancer.

As the core of cellular immunotherapy, T cells are important aspects of research and treatment of lung cancer. IL-6 is a costimulatory signal factor of T cells that is directly targeted by lung cancer...

Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning.

Cancer research is an essential part of national cancer control programmes, and the emerging economies of Central and Eastern Europe (CEE) and the Russian Federation and Central Asia (R-CA) (Commonwea...

Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century.

Translational cancer research covers the whole cancer research continuum from basic to preclinical to early clinical, late clinical and outcomes research. Basic-preclinical research is the "engine" fo...

Clinical Trials [11771 Associated Clinical Trials listed on BioPortfolio]

Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer

There are two parts to this study. The first part of this research study has the purpose of determining the safety of the combination of the two drugs cediranib and olaparib and the highe...

SS-GCC1- Screening Study of Genetic Changes in Colorectal Cancer

the principal research objective is to form a database of tissue samples from patients with colorectal (bowel) cancer. The tissue samples that will be used for this research will have alr...

Early Detection of Breast Cancer in a Mammography Screening

The goal of this research study is to create a bank of research samples and a database of clinical and risk information from women undergoing routine screening mammograms, for use in futur...

Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer

The purpose of this research study is to determine the safety of combining lapatinib plus radiation in patients with breast cancer that has spread to the brain. Depending upon the partici...

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

The purpose of this research study is to determine the safety of the combination of the two drugs cediranib and temsirolimus and the highest doses of these two drugs that can be given in c...

Companies [3287 Associated Companies listed on BioPortfolio]

Cancer Research Ventures

Cancer Research Ventures Ltd (CRV) and its forerunner Cancer Research Campaign Technology Limited (CRCT) have been providing technology transfer services to cancer researchers since 1987 with the aim ...

OncoMed Pharmaceuticals, Inc.

OncoMed is a clinical development-stage biopharmaceutical company focused on discovering and developing first-in-class monoclonal antibody therapeutics targeting cancer stem cells, or CSCs. Our appr...

Palleon Pharmaceuticals

Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer. The company’s proprietary Convergence Pl...

Cancer Research UK

Cancer Research UK is the world's leading independent organisation dedicated to cancer research.With an annual scientific spend of £217 million, we fund over 3,000 world-class scientists, doctors and...

Goodwin Institute for Cancer Research

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a nonprofit cancer research facility dedicated to investigating and studying numerous types of cancer. Our goal is to find a cure or c...

More Information about "Cancer Research Ventures" on BioPortfolio

We have published hundreds of Cancer Research Ventures news stories on BioPortfolio along with dozens of Cancer Research Ventures Clinical Trials and PubMed Articles about Cancer Research Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cancer Research Ventures Companies in our database. You can also find out about relevant Cancer Research Ventures Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record